Study of Co-administered (Types 1 & 2) Novel Oral Poliomyelitis Vaccines Evaluation

计划入组 675 人 · 首次发布于 2025 年 3 月 26 日

Evaluation of the Immunogenicity and Safety of Concomitant Administration of Novel Oral Polio Type 2 Vaccine and Bivalent Oral Polio Vaccine

首次发布于 2021 年 12 月 21 日

Clinical Trial of Novel OPV2 Vaccine

计划入组 330 人 · 首次发布于 2021 年 1 月 5 日

Novel oral polio type 2 vaccine

Novel Oral Polio Vaccine Type 3

Novel Live Attenuated Type 1 Poliomyelitis Vaccines (PATH)

Novel Laboratories, Inc.

United States

Oral-B Laboratories

United States

Philips Oral Healthcare

United States

Biological E Receives WHO Phase II Pre-Qualification for Novel Oral Polio Vaccine Type 2

Novel Oral Polio Vaccines Demonstrate Safety and Efficacy in First-in-Human Phase 1 Trial

Could You Patent the Sun? The Story Behind Jonas Salk's Decision to Forgo the Polio Vaccine Patent